The Diagnostic Experience of Male Rett Syndrome
Launched by CHILDREN'S HOSPITAL COLORADO · Mar 28, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Diagnostic Experience of Male Rett Syndrome study is looking to understand the experiences of parents or caregivers who have a son with Rett Syndrome. This trial gathers important information about how families navigate the process of getting a diagnosis for their son, the types of care he receives, and what health needs are most important to them. By participating, you'll complete an online survey that asks questions related to your experiences and your son's condition.
To join this study, you need to be an English-speaking parent or caregiver of a male child with a confirmed diagnosis of Rett Syndrome, regardless of his age or whether he is currently alive or has passed away. Unfortunately, parents of boys with a specific genetic variation called MECP2 duplication syndrome are not eligible to participate. It’s important to note that there is no compensation for participating in this study, but your insights could help improve understanding and support for families affected by this condition.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • English-speaking parents (over the age of 18) of male children (all ages, alive or deceased) with confirmed genetic diagnosis of male RTT
- Exclusion Criteria:
- • parents of male MECP2 duplication syndrome
About Children's Hospital Colorado
Children's Hospital Colorado is a leading pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and trials. With a commitment to excellence in patient care, education, and community engagement, the hospital collaborates with a network of specialists to conduct rigorous clinical studies that aim to improve treatment outcomes and develop new therapies for childhood diseases. By fostering a supportive environment for research, Children's Hospital Colorado plays a vital role in translating scientific discoveries into practical applications, ensuring that children receive the most effective and cutting-edge care available.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Trial Officials
Timothy Benke, MD, PhD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported